Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00912210 · ClinicalTrials.gov registry record · Phase 1

Higher Protein Diet and Exercise for Optimal Weight Loss in Elderly Women

A Phase 1 study, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
Phase 1
Development phase
31
Enrollment target

NCT00912210: Completed Phase 1 study, sponsored by University of Illinois at Urbana-Champaign.

NCT00912210 is a Phase 1 study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 31 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00912210, a Phase 1 study, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
Phase 1
Development phase
31 participants
Enrollment target

Study Summary

The broad aim is to determine efficacy of a weight loss diet higher in protein and lower in carbohydrate combined with low intensity exercise to favorably impact body composition, bone health, physical function, metabolic disease and quality of life compared to a conventional higher carbohydrate diet in overweight women over age 60.

Interventions

  • DIETARY_SUPPLEMENT Whey protein isolate
  • DIETARY_SUPPLEMENT Maltodextrin powder supplement

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2009-04
Phase Phase 1

What the finished NCT00912210 record still lists

NCT00912210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (48% lower).

The record links to 0 conditions, and to 2 interventions - of which Whey protein isolate is the first listed.

NCT00912210 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00912210 about?

NCT00912210 is a clinical study titled "Higher Protein Diet and Exercise for Optimal Weight Loss in Elderly Women". The broad aim is to determine efficacy of a weight loss diet higher in protein and lower in carbohydrate combined with low intensity exercise to favorably impact body composition, bone health, physical function, metabolic disease and quality of life compared to a conventional higher carbohydrate die...

What is the current status of trial NCT00912210?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 31 participants. The study started on 2009-04.

What interventions are being tested in trial NCT00912210?

The interventions under investigation include: Whey protein isolate (DIETARY_SUPPLEMENT), Maltodextrin powder supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00912210?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00912210's enrollment target sits among peer trials

31 1322nd of 2000 higher than 669 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00912210, the US trial registry maintained by the National Library of Medicine. NCT00912210 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.